BioSpace News Archive

Arguments in the workplace are often unavoidable. There will be differences in opinion, strategy and planning efforts. To help, here are some tips on how to avoid arguments at work.

It’s no secret that artificial intelligence and machine learning play key roles in drug development. This week, multiple companies have advanced their AI programming.

Four years ago, Takeda Pharmaceutical Company and The Center for iPS Cell Research and Application (CiRA) at Kyoto University established a 10-year joint research program. Today, the organizations made an announcement.

It is well-known that women are more likely to get Alzheimer’s disease than men, but exactly why hasn’t been clearly understood. Research presented at the Alzheimer’s Association International Conference (AAIC) in Los Angeles today describes several genes linked to the disease only in men and others related to risk only in women.

GeoVax Labs, Inc. announced that Senior Scientist, Mugdha Vasireddi, PhD, will deliver an oral presentation entitled, A Single Dose of MVA-Based Lassa Virus Vaccine Provides Complete Protection in a Mouse Lethal Challenge Model.

Susan Hickman, Ph.D., has been selected to lead the Indiana University Center for Aging Research at the Regenstrief Institute.

For quite some time, the focus of the cause of Alzheimer’s disease was on beta-amyloid, a protein that accumulates in the brains of individuals with the disease and which appears to cause at least some of the damage that results in memory and cognition issues. There are other candidates, and research appears to be heating up on the role of inflammation.

While Boston tends to get the lion’s share of recognition as the premier biopharma hub on the East Coast of the United States, other cities and states are looking to make their names known as a strong location for the industry.

Pherecydes Pharma and BIOASTER, the French Technology Research Institute for Microbiology and Infectious Diseases, announce the signing of a collaboration agreement.

Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.